Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study (Q84927314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

title

Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Giovanni Della Cioppa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

Timo Vesikari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

Kelly Lindert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

Uwe Nicolay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

publication date

9 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

issue

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

8696-8704

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

Influenza-associated hospitalizations in the United States

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

The underrecognized burden of influenza in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

7 January 2021

Influenza in children

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

The Japanese experience with vaccinating schoolchildren against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Incidence of influenza-related hospitalizations in different age groups of children in Finland: a 16-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Prevention of influenza in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Epitope analysis for influenza vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

7 January 2021

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Influenza vaccine: the challenge of antigenic drift.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.111

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.08.111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21906647 AND SRC:MED&resulttype=core&format=json

12 February 2020

1 reference